The EQUAL study : The EQUAL study: A randomised trial to study the EQUivalence of three monthly intravitreal injections and additional injections as needed of bevacizumab (Avastin ®) and ranibizumab (Lucentis ® ) on visual acuity in patients with exudative age-related macular degeneration.
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2008-05-29, Last updated: 2023-04-06 |
|---|
| ICTRP ID: |
NTR1331 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CTG004345045 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG004345045 | ||
| 003 | DE-627 | ||
| 005 | 20230425175127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2023 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)CTG004345045 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NTR1331 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NL1285 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO): MEC 08-2-037 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)ISRCTN wordt niet meer aangevraagd | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a The EQUAL study |b The EQUAL study: A randomised trial to study the EQUivalence of three monthly intravitreal injections and additional injections as needed of bevacizumab (Avastin ®) and ranibizumab (Lucentis ® ) on visual acuity in patients with exudative age-related macular degeneration. |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2008-05-29, Last updated: 2023-04-06 | ||
| 650 | 4 | |a Medical Condition: Exudative age-related macular degeneration | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Recruitment Status: Not yet recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2023) vom: 03. Apr. |
| 773 | 1 | 8 | |g year:2023 |g day:03 |g month:04 |
| 856 | 4 | 0 | |u https://www.onderzoekmetmensen.nl/en/trial/28472 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 03 |c 04 | ||